Similar Papers

Paper Title
Journal
Date
Author
Optimizing the Safe Washout Period for Liver Transplantation Following Immune Checkpoint Inhibitors with Atezolizumab, Nivolumab, or Pembrolizumab
Fang-Cheng Kuo ... Che-Chuan Loong
Transplantation Proceedings | VOL. 55
Fang-Cheng Kuo, et. al.Fang-Cheng Kuo ... Che-Chuan Loong
29 Apr 2023
Clinical outcome after complete response with immunotherapy in hepatocellular carcinoma.
Pin-Jung Chen ... Hasmik Adetyan
Journal of Clinical Oncology | VOL. 43
Pin-Jung Chen, et. al.Pin-Jung Chen ... Hasmik Adetyan
01 Feb 2025
Oncologic benefit of adjuvant chemotherapy for locally advanced rectal cancer after neoadjuvant chemoradiotherapy and curative surgery with selective lateral pelvic lymph node dissection: An international retrospective cohort study
Yudai Fukui ... Yoshiharu Sakai
European Journal of Surgical Oncology | VOL. 48
Yudai Fukui, et. al.Yudai Fukui ... Yoshiharu Sakai
03 Feb 2022
The outcomes of salvage surgery for non-small cell lung cancer after immune checkpoint inhibitor or targeted therapy treatment. A multi-center international real-life study.
Francesco Guerrera ... Joseph Seitlinger
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology | VOL. 51
Francesco Guerrera, et. al.Francesco Guerrera ... Joseph Seitlinger
01 Jun 2025
View more papers

More From: Hepatology (Baltimore, Md.)

Paper Title
Journal
Date
Author
Long-term mortality and extrahepatic outcomes in 1,096 children with MASLD: A retrospective cohort study.
Jeffrey B Schwimmer ... Cynthia A Behling
Hepatology (Baltimore, Md.) | VOL. -
Jeffrey B Schwimmer, et. al.Jeffrey B Schwimmer ... Cynthia A Behling
22 Apr 2025
AI-based phenotyping of hepatic fiber morphology to inform molecular alterations in metabolic dysfunction-associated steatotic liver disease.
Naoto Fujiwara ... Hayato Nakagawa
Hepatology (Baltimore, Md.) | VOL. -
Naoto Fujiwara, et. al.Naoto Fujiwara ... Hayato Nakagawa
22 Apr 2025
Letter to editor: Comprehensive profiling of lipid metabolic reprogramming expands precision medicine for HCC.
Rui Du ... Shimeng Cui
Hepatology (Baltimore, Md.) | VOL. -
Rui Du, et. al.Rui Du ... Shimeng Cui
22 Apr 2025
Prediction models for liver decompensation in compensated advanced chronic liver disease: a systematic review.
Vincent Haghnejad ... Ian A Rowe
Hepatology (Baltimore, Md.) | VOL. -
Vincent Haghnejad, et. al.Vincent Haghnejad ... Ian A Rowe
22 Apr 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.